NSE filing, NSE: LEXUS. Summary written from the filing by ALFA Finder's alert engine.
Lexus Granito (India) Ltd: key numbers
- Share price
- ₹10.68
- Market cap
- ₹22.20 Cr
- Revenue (annual)
- ₹61.88 Cr
- Net profit (annual)
- ₹1.04 Cr
- P/E (TTM)
- -9.9×Sector 41.7×
- Promoter holding
- 52.91%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lexus Granito (India) Ltd
All →Lexus Granito (India) Annual General Meeting
Lexus Granito (India) Limited held its 18th Annual General Meeting on September 30, 2026. The meeting covered routine resolutions including adoption of financial statements.
Lexus Granito (India) Annual General Meeting
Lexus Granito (India) Limited has filed the Notice for its 18th Annual General Meeting to be held on 30th September, 2026.
Lexus Granito (India) Board Meeting Outcome
Lexus Granito (India) Limited held a board meeting on September 8, 2026, approving the appointment of a Secretarial Auditor and scheduling its 18th AGM.
Lexus Granito (India) Q1 FY27 Results: Net Loss of ₹2.7 Cr
Lexus Granito (India) Ltd reported revenue from operations of ₹3.6 Cr (-80.0% YoY) and a net loss of ₹2.7 Cr for Q1 FY27.
- Key figure
- Net loss ₹2.7 Cr
Lexus Granito (India) Management Change
Lexus Granito (India) Limited appointed M/s. Savjani & Associates as Internal Auditor for a 12-month term. This strengthens the company's internal controls and financial compliance framework.
- Execution
- 12 months
Lexus Granito (India) Financial Results
Lexus Granito (India) Limited reported annual revenue of ₹61.88 Crore for FY26. The company achieved a net profit of ₹1.04 Crore for the full year.
- Value
- ₹61.88 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.